Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Coller

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
The Journal of Clinical Investigation|February 1, 1992
Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusionsB S Coller, K T Springer, J H Beer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adultsA C Mauer, N A Khazanov, N Levenkova, et al.
The Journal of Clinical Investigation|December 1, 1993
Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogenB S Coller, J L Kutok, L E Scudder, et al.
Circulation|February 9, 1999
Rapid platelet-function assay: an automated and quantitative cartridge-based methodJ W Smith, S R Steinhubl, A M Lincoff, et al.
Molecular Immunology|November 1, 1995
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regionsD M Knight, C Wagner, R Jordan, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombastheniaN Rosenberg, H Hauschner, H Peretz, et al.
Circulation|March 1, 1988
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparationH K Gold, B S Coller, T Yasuda, et al.
Circulation|November 11, 1999
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary interventionS R Steinhubl, K Kottke-Marchant, D J Moliterno, et al.
Brain Research|September 5, 2001
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusionZ G Zhang, L Zhang, W Tsang, et al.
Journal of the American College of Cardiology|December 1, 1995
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptorsN S Kleiman, A E Raizner, R Jordan, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
The Journal of Clinical Investigation|February 1, 1992
Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusionsB S Coller, K T Springer, J H Beer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 15, 2010
Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adultsA C Mauer, N A Khazanov, N Levenkova, et al.
The Journal of Clinical Investigation|December 1, 1993
Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogenB S Coller, J L Kutok, L E Scudder, et al.
Circulation|February 9, 1999
Rapid platelet-function assay: an automated and quantitative cartridge-based methodJ W Smith, S R Steinhubl, A M Lincoff, et al.
Molecular Immunology|November 1, 1995
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regionsD M Knight, C Wagner, R Jordan, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombastheniaN Rosenberg, H Hauschner, H Peretz, et al.
Circulation|March 1, 1988
Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparationH K Gold, B S Coller, T Yasuda, et al.
Circulation|November 11, 1999
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary interventionS R Steinhubl, K Kottke-Marchant, D J Moliterno, et al.
Brain Research|September 5, 2001
Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusionZ G Zhang, L Zhang, W Tsang, et al.
Journal of the American College of Cardiology|December 1, 1995
Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptorsN S Kleiman, A E Raizner, R Jordan, et al.
Pageof 17